Literature DB >> 28823857

Cerebral abnormalities in Friedreich ataxia: A review.

Louisa P Selvadurai1, Ian H Harding1, Louise A Corben2, Nellie Georgiou-Karistianis3.   

Abstract

Friedreich ataxia (FRDA) is an inherited degenerative disorder affecting multiple systems of the body and resulting in symptoms which include progressive ataxia, dysarthria, and cardiomyopathy. Central nervous system pathology has been traditionally ascribed to the spinal cord and dentate nucleus of the cerebellum. However, cerebral abnormalities in FRDA are being increasingly documented via multiple neuroimaging techniques. Understanding the nature and implications of cerebral abnormalities in FRDA provides more comprehensive knowledge of nervous system involvement in this disorder and increases the prospects of identifying effective treatment targets. We review the cerebellar and the cerebral involvement with a focus on the emerging in vivo human neuroimaging findings suggesting wide-spread cerebral involvement, including aberrant cerebellar-cerebral connectivity. We synthesise the findings by proposing potential mechanisms that may drive these effects. Finally, we identify future research directions which, we argue, will lead to a better understanding of the extent and potential mechanisms of cerebral aberrations in FRDA.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebro-cerebellar connectivity; Cerebrum; Diffusion tensor imaging (DTI); Friedreich ataxia; Functional magnetic resonance imaging (fMRI); Magnetic resonance imaging (MRI); Neurodegenerative disorder; Neuroimaging; Spino-cerebellar ataxia

Mesh:

Year:  2017        PMID: 28823857     DOI: 10.1016/j.neubiorev.2017.08.006

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  18 in total

1.  Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia.

Authors:  Françoise Piguet; Charline de Montigny; Nadège Vaucamps; Laurence Reutenauer; Aurélie Eisenmann; Hélène Puccio
Journal:  Mol Ther       Date:  2018-05-28       Impact factor: 11.454

2.  Health-related quality of life and depressive symptoms in Friedreich ataxia.

Authors:  Javier Pérez-Flores; Atteneri Hernández-Torres; Fernando Montón; Antonieta Nieto
Journal:  Qual Life Res       Date:  2019-09-28       Impact factor: 4.147

3.  Longitudinal structural brain changes in Friedreich ataxia depend on disease severity: the IMAGE-FRDA study.

Authors:  Ian H Harding; Louise A Corben; Louisa P Selvadurai; Nellie Georgiou-Karistianis; Rosita Shishegar; Cathlin Sheridan; Gary F Egan; Martin B Delatycki
Journal:  J Neurol       Date:  2021-04-15       Impact factor: 4.849

Review 4.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

5.  Natural History of Friedreich's Ataxia: Heterogeneity of Neurological Progression and Consequences for Clinical Trial Design.

Authors:  Christian Rummey; Louise A Corben; Martin Delatycki; George Wilmot; Sub H Subramony; Manuela Corti; Khalaf Bushara; Antoine Duquette; Christopher Gomez; J Chad Hoyle; Richard Roxburgh; Lauren Seeberger; Grace Yoon; Katherine Mathews; Theresa Zesiewicz; Susan Perlman; David R Lynch
Journal:  Neurology       Date:  2022-07-11       Impact factor: 11.800

6.  Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group.

Authors:  Gary F Egan; Paul M Thompson; Ian H Harding; Sidhant Chopra; Filippo Arrigoni; Sylvia Boesch; Arturo Brunetti; Sirio Cocozza; Louise A Corben; Andreas Deistung; Martin Delatycki; Stefano Diciotti; Imis Dogan; Stefania Evangelisti; Marcondes C França; Sophia L Göricke; Nellie Georgiou-Karistianis; Laura L Gramegna; Pierre-Gilles Henry; Carlos R Hernandez-Castillo; Diane Hutter; Neda Jahanshad; James M Joers; Christophe Lenglet; Raffaele Lodi; David N Manners; Alberto R M Martinez; Andrea Martinuzzi; Chiara Marzi; Mario Mascalchi; Wolfgang Nachbauer; Chiara Pane; Denis Peruzzo; Pramod K Pisharady; Giuseppe Pontillo; Kathrin Reetz; Thiago J R Rezende; Sandro Romanzetti; Francesco Saccà; Christoph Scherfler; Jörg B Schulz; Ambra Stefani; Claudia Testa; Sophia I Thomopoulos; Dagmar Timmann; Stefania Tirelli; Caterina Tonon; Marinela Vavla
Journal:  Ann Neurol       Date:  2021-09-17       Impact factor: 11.274

7.  Safety and Biodistribution of Human Bone Marrow-Derived Mesenchymal Stromal Cells Injected Intrathecally in Non-Obese Diabetic Severe Combined Immunodeficiency Mice: Preclinical Study.

Authors:  Mari Paz Quesada; David García-Bernal; Diego Pastor; Alicia Estirado; Miguel Blanquer; Ana Mª García-Hernández; José M Moraleda; Salvador Martínez
Journal:  Tissue Eng Regen Med       Date:  2019-07-26       Impact factor: 4.169

Review 8.  Recessive cerebellar and afferent ataxias - clinical challenges and future directions.

Authors:  Marie Beaudin; Mario Manto; Jeremy D Schmahmann; Massimo Pandolfo; Nicolas Dupre
Journal:  Nat Rev Neurol       Date:  2022-03-24       Impact factor: 42.937

Review 9.  Hepcidin, an emerging and important player in brain iron homeostasis.

Authors:  Driton Vela
Journal:  J Transl Med       Date:  2018-02-07       Impact factor: 5.531

10.  Cerebellar cognitive disorder parallels cerebellar motor symptoms in Friedreich ataxia.

Authors:  Gilles Naeije; Myriam Rai; Nick Allaerts; Martin Sjogard; Xavier De Tiège; Massimo Pandolfo
Journal:  Ann Clin Transl Neurol       Date:  2020-06-08       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.